Publication | Closed Access

1373MO JUPITER-06: A randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC)

Esophageal CancerMedicinePathologyToripalimab Versus PlaceboPhase Iii StudyCancer TreatmentFirst-line ChemotherapyOncologyRadiation OncologyCancer ResearchMolecular Oncology